美国NDC复合药物数据库文件

药品名称：商品名称：药品NDC：报告期内： -格式:2020-5-3
NDC包装id：市场分类：活性成分：持证企业：

美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)

药品名称(分析)

商品名

药品NDC

专利人(分析)

报告期内

活性成分

市场分类

规格(分析)

NDC包装id

TESTOSTERONE C 200MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

200 mg

70713-055-01

ESTRADIOL 12.5MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

12.5 mg

70713-148-01

TESTOSTERONE ANASTROZOLE SA2 100MG 4MG

HUMAN COMPOUNDED DRUG

70713-043

Wells Pharmacy, Inc

2024-2

TESTOSTERONE; ANASTROZOLE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

100 mg; 4 mg

70713-043-01

TESTOSTERONE SA2 100MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

100 mg

70713-002-01

TESTOSTERONE SA2 62.5MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

62.5 mg

70713-033-01

TESTOSTERONE ANASTROZOLE SA2 200MG 8MG

HUMAN COMPOUNDED DRUG

70713-034

Wells Pharmacy, Inc

2024-2

TESTOSTERONE; ANASTROZOLE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

200 mg; 8 mg

70713-034-01

TESTOSTERONE SA2 37.5MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

37.5 mg

70713-008-01

Tropicamide, Phenylephrine Hydrochloride

HUMAN COMPOUNDED DRUG

71449-098

Denver Solutions, LLC dba Leiters Health

2024-2

TROPICAMIDE; PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL; 25 mg/1 mL

71449-098-47

Glycopyrrolate

HUMAN COMPOUNDED DRUG

71449-104

Denver Solutions, LLC dba Leiters Health

2024-2

GLYCOPYRROLATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.2 mg/1 mL

71449-104-11

Lidocaine Hydrochloride, Phenylephrine Hydrochloride

HUMAN COMPOUNDED DRUG

71449-184

Denver Solutions, LLC dba Leiters Health

2024-2

LIDOCAINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL; 15 mg/1 mL

71449-184-03

Trophamine 3% / Dextrose 5% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag

HUMAN COMPOUNDED DRUG

72196-0413

Central Admixture Pharmacy Services, Inc.

2024-2

GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; CALCIUM GLUCONATE MONOHYDRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 12.5 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; 3.75 meq/250 mL

72196-0413-1

Vancomycin 1.25gm added to NS

HUMAN COMPOUNDED DRUG

72196-6074

Central Admixture Pharmacy Services, Inc.

2024-2

VANCOMYCIN HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1.25 g/250 mL

72196-6074-1

Vancomycin 1.5gm added to D5W

HUMAN COMPOUNDED DRUG

72196-6075

Central Admixture Pharmacy Services, Inc.

2024-2

VANCOMYCIN HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1.5 g/250 mL

72196-6075-1

Phenylephrine 25mg added to NS

HUMAN COMPOUNDED DRUG

71285-7011

Central Admixture Pharmacy Services, Inc.

2024-2

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

25 mg/250 mL

71285-7011-1

Maintenance 4 to1 Low K (30 meq) In PL A

HUMAN COMPOUNDED DRUG

71285-0211

Central Admixture Pharmacy Services, Inc.

2024-2

LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM GLUCONATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

200 mg/1047 mL; 1.848 g/1047 mL; 3.68 g/1047 mL; 2.605 g/1047 mL; .3 g/1047 mL; 5.26 g/1047 mL; 5.02 g/1047 mL

71285-0211-1

Phenylephrine 10mg added to NS

HUMAN COMPOUNDED DRUG

71285-6058

Central Admixture Pharmacy Services, Inc.

2024-2

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/250 mL

71285-6058-1

Phenylephrine 20mg added to NS

HUMAN COMPOUNDED DRUG

71285-7025

Central Admixture Pharmacy Services, Inc.

2024-2

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

20 mg/250 mL

71285-7025-1

Induction 4 to1 High K (60mEq) 830ml Bag

HUMAN COMPOUNDED DRUG

71285-0100

Central Admixture Pharmacy Services, Inc.

2024-2

SODIUM CHLORIDE; CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; ANHYDROUS DEXTROSE; TROMETHAMINE; POTASSIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; DEXTROSE MONOHYDRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

18.8 meq/830 mL; 1.635 g/830 mL; 13.15 g/830 mL; 23.2 g/830 mL; 7.2 g/830 mL; 60 meq/830 mL; 1.11 g/830 mL; 49.45 g/830 mL

71285-0100-1

Maintenance 4 to1 Low K (20 mEq) 810ml Bag

HUMAN COMPOUNDED DRUG

71285-0103

Central Admixture Pharmacy Services, Inc.

2024-2

CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE; SODIUM CHLORIDE; TROMETHAMINE; POTASSIUM CHLORIDE; DEXTROSE MONOHYDRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1.635 g/810 mL; 13.15 g/810 mL; 1.11 g/810 mL; 23.2 g/810 mL; 18.8 meq/810 mL; 7.2 g/810 mL; 20 meq/810 mL; 49.45 g/810 mL

71285-0103-1

Benzocaine Lidocaine Tetracaine 20/6/4

HUMAN COMPOUNDED DRUG

26436-5200

Hybrid Pharma

2024-2

BENZOCAINE; TETRACAINE; LIDOCAINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

200 mg/1 g; 40 mg/1 g; 60 mg/1 g

26436-5200-4

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：